AI is revolutionizing the field of oncology, with researchers at Fred Hutch harnessing its power to tackle complex challenges in cancer treatment and diagnosis. In this article, we delve into the innovative projects of three scientists who are utilizing AI to make significant strides in their respective areas of research.
AI-Assisted Cell Identity and Vaccine Development
David Glass, a postdoctoral researcher, is leveraging AI to understand the identity of B cells and their role in vaccine development. By interactively coding with AI, Glass aims to determine which B cell types are optimal for a durable response, enabling the creation of tailored vaccines. This approach, he believes, will enhance the effectiveness of vaccines and potentially lead to more personalized medicine.
Predicting Prostate Cancer Treatment Response with AI
Lucas Liu, a statistical programmer and postdoctoral researcher, is working on a groundbreaking project to predict treatment response to immunotherapy in prostate cancer patients. The current process of molecular testing is costly and only applicable to a small percentage of patients with MSI-high tumors. Liu's AI tool, however, shows promise in predicting MSI-high profiles from pathology images, potentially making precision oncology more accessible and equitable. The next step is to further validate the tool and explore its ability to directly predict treatment response.
AI-Powered Analysis of 'Limbo' Cells in Head and Neck Cancer
Sarah Huang, a graduate student, is using AI to study the recurrence of head and neck squamous cell carcinoma. The disease's rapid relapse despite surgical removal of the tumor has intrigued Huang. She hypothesizes that signaling from the tumor may have altered nearby cells, pushing them into a state of limbo, which could contribute to cancer recurrence. By characterizing these 'limbo' cells and examining their communication patterns, Huang aims to identify high-risk tissue more precisely, potentially improving surgical outcomes.
These projects showcase the diverse applications of AI in oncology, from understanding cell identity to predicting treatment responses and analyzing complex cellular behaviors. As AI continues to advance, its integration into cancer research and clinical practice is expected to grow, offering new hope for patients and researchers alike.
